| 國立臺灣大學 |
2004 |
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
|
廖運範; 李嘉哲; LIAW, YUN-FAN; SUNG JOSEPH J.Y.; CHOW WAN-CHENG; GEOFFREY FARRELL; LEE, CHA-ZE; YUEN HON; TAWESAK TANWANDEE; TAO QI-MIN; KELLY SHUE; OLIVER N. KEENE; JONATHAN S. DIXON; D. FRASER GRAY; JAN SABBAT |
| 臺大學術典藏 |
2021-02-02T07:51:01Z |
Lamivudine for patients with chronic hepatitis B and advanced liver disease
|
Liaw Y.-F.; Sung J.J.Y.; Chow W.C.; Farrell G.; Lee, Cha-Ze; Yuen H.; Tanwandee T.; Tao Q.-M.; Shue K.; Keene O.N.; Dixon J.S.; Gray D.F.; Sabbat J. |
| 臺大學術典藏 |
2018-09-10T07:27:25Z |
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: A multicentre, randomized, double-blind, placebo-controlled study
|
Xu, W.-M.;Cui, Y.-T.;Wang, L.;Yang, H.;Liang, Z.-Q.;Li, X.-M.;Zhang, S.-L.;Qiao, F.-Y.;Campbell, F.;Chang, C.-N.;Gardner, S.;Atkins, M.; HUNG-CHIH YANG |
| 臺大學術典藏 |
2018-09-10T03:23:08Z |
Lamivudine treatment for hbv infection in patients receiving hematopoietic stem cell transplantation in ntuh
|
Lee, C.C. and Yao, M. and Lai, M. and Tang, J.L. and Chen, Y.C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-01-06T03:58:59Z |
Lamivudine treatment for hbv infection in patients receiving hematopoietic stem cell transplantation in ntuh
|
Lee C.C.; Yao M.; Lai M.; JIH-LUH TANG; Chen Y.C. |
| 臺大學術典藏 |
2018-09-10T03:41:08Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu, C.-J.;Lai, M.-Y.;Lee, P.-H.;Chou, N.-K.;Chu, S.-H.;Chen, P.-J.;Kao, J.-H.;Jen, Y.-M.;Chen, D.-S.Po-Huang Lee;Nai-Kuan Chou;Chun-Jen Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; Liu, C.-J.; Lai, M.-Y.; Lee, P.-H.; Chou, N.-K.; Chu, S.-H.; Chen, P.-J.; Kao, J.-H.; Jen, Y.-M.; Chen, D.-S. |
| 國立臺灣大學 |
2001 |
Lamivudine Treatment for Hepatitis B Reactivation in Hbsag Carriers after Organ Transplantation: A 4-Year Experience
|
劉俊人; 李伯皇; 陳定信; 賴明陽; LIU, CHUN-JEN; LEE, PO-HUANG; CHEN, DING-SHINN; LAI, MING-YANG |
| 臺大學術典藏 |
2020-03-09T07:31:18Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu C.-J.;Lai M.-Y.;Lee P.-H.;Nai-Kuan Chou;Chu S.-H.;Chen P.-J.;Kao J.-H.;Jen Y.-M.;Chen D.-S.; Liu C.-J.; Lai M.-Y.; Lee P.-H.; NAI-KUAN CHOU; Chu S.-H.; Chen P.-J.; Kao J.-H.; Jen Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2020-11-19T03:43:09Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu C.-J.;Lai M.-Y.;Po-Huang Lee;Chou N.-K.;Chu S.-H.;Chen P.-J.;Kao J.-H.;Jen Y.-M.;Chen D.-S.; Liu C.-J.; Lai M.-Y.; PO-HUANG LEE; Chou N.-K.; Chu S.-H.; Chen P.-J.; Kao J.-H.; Jen Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:19Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu C.-J.; Lai M.-Y.; Lee P.-H.; Chou N.-K.; Chu S.-H.; Chen P.-J.; JIA-HORNG KAO; Jen Y.-M.; Chen D.-S. |
